UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.673

Sortiert nach

Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review

Cancer letters, 2018-02, Vol.414, p.166-173

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Signal transduction and targeted therapy, 2022-07, Vol.7 (1), p.258-258, Article 258

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy

Cancer treatment reviews, 2015-12, Vol.41 (10), p.868-876

2015

Link zum Volltext

Verfügbarkeit prüfen

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.87-13, Article 87

2019

Link zum Volltext

Verfügbarkeit prüfen

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Journal of hematology and oncology, 2018-08, Vol.11 (1), p.104-104, Article 104

2018

Link zum Volltext

Verfügbarkeit prüfen

Recent Development of pH-Responsive Polymers for Cancer Nanomedicine

Molecules (Basel, Switzerland), 2018-12, Vol.24 (1), p.4

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications

BMC medicine, 2020-09, Vol.18 (1), p.275-8, Article 275

2020

Link zum Volltext

Verfügbarkeit prüfen

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges

Journal of hematology and oncology, 2020-07, Vol.13 (1), p.105-17, Article 105

2020

Link zum Volltext

Verfügbarkeit prüfen

The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis

Scientific reports, 2017-06, Vol.7 (1), p.4231-8, Article 4231

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis

PloS one, 2016-01, Vol.11 (1), p.e0146195-e0146195

2016

Link zum Volltext

Verfügbarkeit prüfen

Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors

Frontiers in oncology, 2020-12, Vol.10, p.602762-602762

2020

Link zum Volltext

Verfügbarkeit prüfen

Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC

Cancer letters, 2018-04, Vol.418, p.1-9

2018

Link zum Volltext

Verfügbarkeit prüfen

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

Journal of hematology and oncology, 2017-04, Vol.10 (1), p.81-81, Article 81

2017

Link zum Volltext

Verfügbarkeit prüfen

The landscape of bispecific T cell engager in cancer treatment

Biomarker research, 2021-05, Vol.9 (1), p.1-23, Article 38

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients

BMC cancer, 2024-02, Vol.24 (1), p.197-197

2024

Link zum Volltext

Verfügbarkeit prüfen

MiR‐216a‐3p inhibits colorectal cancer cell proliferation through direct targeting COX‐2 and ALOX5

Journal of cellular biochemistry, 2018-02, Vol.119 (2), p.1755-1766

2018

Link zum Volltext

Verfügbarkeit prüfen

The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy

Cancer biology & medicine, 2019-11, Vol.16 (4), p.655-670

2019

Link zum Volltext

Verfügbarkeit prüfen

PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges

Cancer letters, 2017-10, Vol.405, p.29-37

2017

Link zum Volltext

Verfügbarkeit prüfen

A good start of immunotherapy in esophageal cancer

Cancer medicine (Malden, MA), 2019-08, Vol.8 (10), p.4519-4526

2019

Link zum Volltext

Verfügbarkeit prüfen

Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice

Frontiers in immunology, 2020-05, Vol.11, p.1088

2020

Link zum Volltext

Verfügbarkeit prüfen

Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer

International immunopharmacology, 2024-02, Vol.128, p.111489-111489, Article 111489

2024

Link zum Volltext

Verfügbarkeit prüfen

Associations between Diabetes and Quality of Life among Breast Cancer Survivors

PloS one, 2016-06, Vol.11 (6), p.e0157791-e0157791

2016

Link zum Volltext

Verfügbarkeit prüfen

The addition of anlotinib reduces the incidence of radiation and immunotherapy-induced pneumonia

Journal of translational medicine, 2023-10, Vol.21 (1), p.1-683, Article 683

2023

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors

Frontiers in oncology, 2022-03, Vol.12, p.837952-837952

2022

Link zum Volltext

Verfügbarkeit prüfen

Fucoidan Promotes Apoptosis and Inhibits EMT of Breast Cancer Cells

Biological and Pharmaceutical Bulletin, 2019/03/01, Vol.42(3), pp.442-447

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.673

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.466)
Mit Volltextzugriff
(1.571)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(35)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Recent Development of pH-Responsive Polymers for Cancer Nanomedicine

Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges

The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis

Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis

Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors

Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

The landscape of bispecific T cell engager in cancer treatment

Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients

MiR‐216a‐3p inhibits colorectal cancer cell proliferation through direct targeting COX‐2 and ALOX5

The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy

PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges

A good start of immunotherapy in esophageal cancer

Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice

Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer

Associations between Diabetes and Quality of Life among Breast Cancer Survivors

The addition of anlotinib reduces the incidence of radiation and immunotherapy-induced pneumonia

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors

Fucoidan Promotes Apoptosis and Inhibits EMT of Breast Cancer Cells

Suchergebnisse filtern